4th Edition of
International Ophthalmology Conference
March 23-25, 2026 | Singapore
Genetics, Biomarkers, and Personalized Eye Care
The era of individualized medicine has arrived in ophthalmology through genetics, biomarkers, and personalized eye care. By decoding patient-specific genetic profiles, clinicians can now identify inherited risk for eye diseases such as Leber congenital amaurosis, primary congenital glaucoma, or AMD. Biomarkers, whether molecular or imaging-based, provide additional layers of prognostic data and guide treatment selection. Personalized care means shifting from reactive to predictive strategies—intervening before irreversible damage occurs. The field is also advancing gene therapy and targeted biologics, which offer hope for previously untreatable conditions. Ethical considerations around genetic counseling and data privacy continue to evolve alongside scientific innovation. As new therapies emerge from clinical trials, precision medicine will reshape how patients are screened, monitored, and treated in everyday practice.
Shadrokh Nabili
University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Anna Maria Bassi
University of Genoa, Italy
Tim Jackson
King’s College London, United Kingdom
Pio Conti
University of Chieti, Italy
Gowhar Ahmad
Florence Hospital Srinagar, India
Agnieszka Rosa
Orticus Center for the Treatment of Strabismus and Vision Disorders, Poland
Arrane Selvamogan
Leicestershire Partnership NHS Trust, United KingdomSubmit your abstract Today
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : An advanced 3D human-based in vitro model to identify disease-specific molecular markers of glaucoma neurodegeneration
Anna Maria Bassi, University of Genoa, Italy
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom
Title : Evaluating the quality and readability of AI-generated ophthalmic surgery education: A four-model comparison
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom